PAIGE APPLAB
LIVE

Serial Number

97106715

Owner

Paige.AI, Inc.

Attorney

Mark Leonardo

First Use Date

Feb 9, 2023

Filing Date

Nov 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PAIGE APPLAB Trademark

Serial Number: 97106715 • Registration: 8152125

PAIGE APPLAB is a trademark filed by Paige.AI, Inc. on November 3, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Paige.AI, Inc.

11 Times Square, 37th Floor
New York, NY 10036

Entity Type: 03

Trademark Details

Filing Date

November 3, 2021

Registration Date

February 24, 2026

First Use Anywhere

February 9, 2023

First Use in Commerce

February 9, 2023

Published for Opposition

November 8, 2022

Goods & Services

Software as a service (SaaS) services featuring software for use in the analysis of clinical pathology slides using artificial intelligence (AI), machine learning, deep learning, statistical learning, data mining, and contextual prediction; medical and scientific testing services for research purposes using artificial intelligence (AI), machine learning, deep learning, statistical learning, data mining, and contextual prediction; Software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; Software as a service (SaaS) services featuring software for use in diagnosis, detection, identification, detecting predispositions, detecting recurrence, evaluation of prognosis and monitoring of diseases, states, or conditions; Software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; Software as a service (SaaS) services featuring software for use in clinical management, in the selection of treatment of, use in prevention of, palliation or treatment, of diseases, states, or conditions; Software as a service (SaaS) services featuring software for use in research or development in the field of life sciences, medicine, healthcare, cancer, oncology and pathology; Software as a service (SaaS) services featuring software to convert patient image data into computer models for medical study of patient anatomy, to diagnose medical conditions, to analyze and annotate medical images, reviewing, interpreting, managing and navigating digital images of pathology slides prepared from tissue for diagnosing disease states, viewing images and managing analyses, and for enabling virtual networks across various pathology departments and pathology laboratories having various laboratory information systems to access the images and analyses; design and development of AI powered computer software that analyzes clinical pathology slides and diagnoses diseases through the use of AI powered computer software; medical and scientific research in the fields of clinical pathology and diseases using AI powered computer software; medical and scientific research and development services in the field of medicine, healthcare, cancer, oncology, life sciences and pathology; medical and scientific testing services for research purposes; providing medical research and scientific research information in the fields of in vitro diagnostics and clinical pathology research and testing via the internet; and electronic scanning of clinical pathology slide

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 24, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 5, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 5, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 23, 2025 SUPC
USE AMENDMENT FILED
Dec 19, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 19, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2025 EXRA
SOU EXTENSION 5 GRANTED
Oct 4, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 4, 2025 AITU
SOU TEAS EXTENSION RECEIVED
May 22, 2025 EEXT
SOU EXTENSION 5 FILED
May 21, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 3, 2024 EX4G
SOU EXTENSION 4 FILED
Dec 3, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 3, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 3, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 29, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 29, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 29, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 29, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 27, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 27, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 27, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 6, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 6, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 6, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 6, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 18, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 13, 2021 NWOS
NEW APPLICATION ENTERED
Nov 6, 2021 NWAP